148 related articles for article (PubMed ID: 36197455)
1. Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway.
Zhang X; Zuo L; Geng Z; Song X; Li J; Ge S; Jiang Y; Yang Z; Liu G; Zhao Y; Zhao H; Yu L; Hu J
FASEB J; 2022 Nov; 36(11):e22589. PubMed ID: 36197455
[TBL] [Abstract][Full Text] [Related]
2. Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling.
Ge S; Yang Y; Zuo L; Song X; Wen H; Geng Z; He Y; Xu Z; Wu H; Shen M; Ge Y; Sun X
Eur J Pharmacol; 2023 Feb; 940():175464. PubMed ID: 36566007
[TBL] [Abstract][Full Text] [Related]
3. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling.
Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L
Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952
[TBL] [Abstract][Full Text] [Related]
4. Peiminine ameliorates Crohn's disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal.
Qiu Q; Geng Z; Wang L; Zuo L; Deng M; Zhang H; Yang Y; Wang Y; Zhao Z; Wen H; Wang Q; Wang Y; He X; Li J; Wang Y; Zhang X; Liu M; Song X
Int Immunopharmacol; 2024 Jul; 136():112380. PubMed ID: 38850790
[TBL] [Abstract][Full Text] [Related]
5. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling.
Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J
Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862
[TBL] [Abstract][Full Text] [Related]
6. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway.
Zhang M; Song X; Liu S; Zhang N; Yang M; Gao P; Geng Z; Zuo L; Zhang X; Wang L; Wang Y; Li J; Hu J
Int Immunopharmacol; 2024 Jun; 134():112181. PubMed ID: 38733829
[TBL] [Abstract][Full Text] [Related]
7. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition.
Huai M; Zeng J; Ge W
Int Immunopharmacol; 2021 Feb; 91():107284. PubMed ID: 33359851
[TBL] [Abstract][Full Text] [Related]
8. Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling.
Li Q; Li J; Yin L; Huang J; Liu X; Shi J; Geng Z; Song X; Wang L; Wang Y; Zhang X; Zuo L; Hu J
Int Immunopharmacol; 2024 Apr; 131():111886. PubMed ID: 38493691
[TBL] [Abstract][Full Text] [Related]
9. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis
Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165
[TBL] [Abstract][Full Text] [Related]
10. [Prunetin inhibits TLR4/MyD88 pathway to attenuate intestinal epithelial inflammatory response and ameliorate mouse Crohn's disease-like colitis].
Li J; Sun Y; Xiong X; Wang M; Zuo L; Wang Y; Geng Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):199-206. PubMed ID: 38512029
[TBL] [Abstract][Full Text] [Related]
11. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease.
Zhou L; Zhu L; Wu X; Hu S; Zhang S; Ning M; Yu J; Chen M
BMC Med; 2023 Aug; 21(1):287. PubMed ID: 37542259
[TBL] [Abstract][Full Text] [Related]
12. Epac-2 ameliorates spontaneous colitis in Il-10
Song X; Wen H; Zuo L; Geng Z; Nian J; Wang L; Jiang Y; Tao J; Zhu Z; Wu X; Wang Z; Zhang X; Yu L; Zhao H; Xiang P; Li J; Shen L; Hu J
J Cell Mol Med; 2022 Jan; 26(1):216-227. PubMed ID: 34862717
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
14. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study.
Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L
EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187
[TBL] [Abstract][Full Text] [Related]
15. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
16. Aloin A prevents ulcerative colitis in mice by enhancing the intestinal barrier function via suppressing the Notch signaling pathway.
Jiang H; Shi GF; Fang YX; Liu YQ; Wang Q; Zheng X; Zhang DJ; Zhang J; Yin ZQ
Phytomedicine; 2022 Nov; 106():154403. PubMed ID: 36075180
[TBL] [Abstract][Full Text] [Related]
17. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
[TBL] [Abstract][Full Text] [Related]
18. Sanhuang Xiexin decoction ameliorates DSS-induced colitis in mice by regulating intestinal inflammation, intestinal barrier, and intestinal flora.
Wu X; Fu S; Jiang M; Wang J; Tang H; Fang C; Li W; Fu C
J Ethnopharmacol; 2022 Oct; 297():115537. PubMed ID: 35843414
[TBL] [Abstract][Full Text] [Related]
19. Administration of geniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage.
Zhang Z; Li Y; Shen P; Li S; Lu X; Liu J; Cao Y; Liu B; Fu Y; Zhang N
Int Immunopharmacol; 2017 Aug; 49():168-177. PubMed ID: 28595080
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
